SCHEMBL5780283

SCHEMBL5780283

O=C1c2ccccc2C(=O)N1CCCC1N(C(=O)c2cccc(F)c2F)c2ccc(Cl)cc2C12CCNCC2

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 7/20 0.36
DRD2 P14416 3/20 0.36
DRD3 P35462 2/20 0.36
DRD1 P21728 1/20 0.35
CHRM1 P11229 3/20 0.34
CHRM3 P20309 3/20 0.34
CHRM2 P08172 1/20 0.34
CHRM4 P08173 1/20 0.34
CHRM5 P08912 1/20 0.34
MAPT P10636 2/20 0.33
HDAC3 O15379 1/20 0.33
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
HDAC4 P56524 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
HDAC1 Q13547 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5779841 0.98 DRD2 (0.38) PTGDR2DRD2DRD3DRD1CHRM1
SCHEMBL5599761 0.91 CHRM1 (0.39) PTGDR2DRD2DRD3CHRM1CHRM3
SCHEMBL5599289 0.87 DRD2 (0.37) PTGDR2DRD2CHRM1CHRM3CHRM2
SCHEMBL5783150 0.84 PTGDR2 (0.36) PTGDR2DRD2CHRM1CHRM3CHRM2
SCHEMBL5599571 0.81 PTGDR2 (0.37) PTGDR2DRD2CHRM1CHRM3CHRM2
SCHEMBL5600563 0.81 TSHR (0.36) PTGDR2DRD2CHRM1CHRM3CHRM2
SCHEMBL5599763 0.80 DRD2 (0.38) PTGDR2DRD2CHRM1CHRM3CHRM2
SCHEMBL5780173 0.79 DRD2 (0.36) PTGDR2DRD2DRD1CHRM1CHRM3
SCHEMBL5779582 0.78 P2RX7 (0.41) PTGDR2DRD2CHRM1CHRM3KCNH2
SCHEMBL5782575 0.77 GPR183 (0.34) PTGDR2DRD2CHRM1CHRM3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP claimed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO claimed